World of DTC Marketing

SEPTEMBER 12, 2022

Apple’s Health app gets new capabilities with iOS 16. The Health app adds Medications, allowing users to conveniently build and manage a medications list, create schedules and reminders, and track their medications, vitamins, or supplements. Will it matter? The health app will also tell users about potential interactions between medications, and it’s possible to connect with healthcare providers to see a list of past medications, get future updates, or add items to your schedule.

Medical 166

Medical Healthcare Provider Doctors Physicians 166

Pharmaceutical Technology

SEPTEMBER 13, 2022

Novo Nordisk has signed a new strategic partnership with Microsoft to expedite the discovery and development of drugs leveraging big data and artificial intelligence (AI). Under the deal, Microsoft's computational services, Cloud and artificial intelligence (AI) will be merged with the drug discovery, development and data science expertise of Novo Nordisk.

Training 139

Training Leads Pharmaceutical Patients 139

pharmaphorum

SEPTEMBER 16, 2022

Alphabet subsidiary and precision health company Verily recently announced a breakthrough in its AI drug discovery GPCR research collaboration with Sosei Heptares. A mere six months ago Verily launched the study with Sosei Heptares – a global leader in GPCR structure-based drug design – with an aim to “prioritise protein targets for therapeutic targeting in immune-mediated disease”.

Leads 135

Leads Patients Medicine FDA 135

MedCity News

SEPTEMBER 16, 2022

The problem with the US healthcare system is one of misaligned incentives. Prescribers are paid to evaluate patients and to administer care. All prescribers want the best outcomes for their patients, but the system does not incentivize choosing the best medications to promote those outcomes. Instead it is incentivized to pay for only the medications prescribed.

Healthcare 130

Healthcare Healthcare Medical Patients 130

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

PharmExec

SEPTEMBER 10, 2022

FDA backs the benefits of adopting continuous manufacturing, a strategy which has accelerated approval and launch timelines, and its Emerging Technology Program could be a helpful tool.

Manufacturing 130

Manufacturing Marketing FDA 130

Medgadget

SEPTEMBER 10, 2022

Researchers at the University of Bern in Switzerland have developed a motion tracking system that is intended to assist in detecting age-related disease in elderly people. The system could be installed in someone’s home or in assisted-living facilities, and consists of a series of motion sensors that can monitor for signs of unusual movement. The system can inform caregivers if an emergency arises, such as a fall, which can be detected when someone does not return to their bed at night or is sta

Medicine 115

Medicine Healthcare Healthcare Medical 115

MedCity News

SEPTEMBER 13, 2022

By following the patient at each stage of its disease progression, from diagnosis to disease management, and integrating a variety of technologies, digital health provides deeper insights and help for care management.

Management 130

Management Patients 130

PharmaTimes

SEPTEMBER 12, 2022

Collaboration will involve sophisticated screening for cardiac-based drug discovery

113

113

European Pharmaceutical Review

SEPTEMBER 12, 2022

Novartis has revealed plans to invest $300 million in next-generation biotherapeutics. The multi-year investment will be implemented across existing Novartis locations in Switzerland, Slovenia and Austria to create a fully integrated, “dedicated scientific environment will bolster its capacity and capabilities for early technical development of biologics”.

Manufacturing 111

Manufacturing Pharmaceutical Patients 111

Pharmaceutical Technology

SEPTEMBER 16, 2022

Gilead Sciences has received expanded recommendation under the World Health Organization’s (WHO) Therapeutics and COVID-19: living guideline for the use of Veklury (remdesivir) to treat severe Covid-19 patients. The guideline update comes after the treatment received recommendation from the health agency for treating non-severe Covid-19 in patients at increased risk of hospitalisation.

Food and Drug Administration 110

Food and Drug Administration Food Patients Medical 110

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

MedCity News

SEPTEMBER 16, 2022

Medsembly, an Atlanta-based startup that connects students who want to get into healthcare with working professionals in their prospective careers, launched an interactive digital mentoring platform. The platform allows students to connect with healthcare professionals who can give them advice on things like how to get into medical school, how to land a residency and what day-to-day activities they can expect in their prospective career.

Healthcare 115

Healthcare Healthcare Prospecting Medical 115

PharmaTimes

SEPTEMBER 13, 2022

Up-LIFT research achieves primary endpoint with improvement in arm and hand function

111

111

Medgadget

SEPTEMBER 13, 2022

Researchers at the University of the Basque Country have developed a technique that allows them to 3D print pharmaceutical tablets using different types of starch. By modifying the types of starch used and the shape of the tablets, the team can fine-tune drug release to be either rapid or slow. This includes full release of the encapsulated drug in as little as ten minutes to as long as six hours, providing significant scope to address a wide variety of therapeutic situations.

Medicine 108

Medicine Specialization Patients Networking 108

Pharmaceutical Technology

SEPTEMBER 15, 2022

Last year was a positive year for biopharmaceutical companies, particularly those with Covid-19 vaccines. The top 13 players reported more than 10% revenue growth, with BioNTech (3,834.4%), Moderna (2,199.1%), Pfizer (95.2%) and Regeneron Pharmaceuticals (89.1%) reporting a more than 80% year-on-year (YoY) revenue growth from 2020 to 2021, according to GlobalData’s Pharma Intelligence Centre Companies Database.

Sales 108

Sales Competition Pharmaceutical Pharmaceutical research 108

Advertisement

MedCity News

SEPTEMBER 15, 2022

CarePoint Health, a three-hospital health system in New Jersey, recently filed a lawsuit against RWJBarnabas Health, the largest acute care provider in the state. The complaint alleged that RWJBarnabas conspired with real estate investors, New Jersey’s largest payer and government officials to eliminate competition and monopolize acute care services in the state.

Government 111

Government Competition 111

PharmaTimes

SEPTEMBER 16, 2022

Therapy has been developed for the prevention of disease in infants

110

110

pharmaphorum

SEPTEMBER 13, 2022

The FDA has started a priority review of Chiesi ‘s velmanase alfa, an enzyme replacement therapy for lysosomal storage disease (LSD) alpha-mannosidosis, with a decision expected in the first half of 2023. The vanishingly rare, progressive, and debilitating disease is caused by a deficiency in the enzyme alpha-mannosidase, leading to a build-up of complex sugars that damage the central nervous system and organs of the body.

FDA 105

FDA Distribution Prospecting Patients 105

Copyright Clearance Center

SEPTEMBER 13, 2022

Sept. 13, 2022 – Danvers, Mass. – CCC , a leading provider of Open Access (OA) workflow solutions, has launched OA Agreement Intelligence , the only agreement modeling solution that enables publishers to prepare, build, and analyze their OA data so that they can create and communicate sustainable and transparent agreements with their partners. The solution combines sophisticated data preprocessing with easy-to-use analysis and export capabilities.

Management 105

Management Leads Marketing 105

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Safety

MedCity News

SEPTEMBER 16, 2022

As consumers better understand their right to medical privacy, they will have higher expectations for wellness wearables that aren’t bound to data privacy regulations.

FDA 111

FDA Medical 111

PM360

SEPTEMBER 15, 2022

Can an art installation teach you about a disease? How about a song? Or a dance? Can more than 20 pharma companies unite around messaging for biomarker testing even though everyone seems to call it something different? And can the mistrust and skepticism minority communities have toward the healthcare system be overcome to spread crucial disease awareness?

Education 105

Education Physicians Pharma Patients 105

pharmaphorum

SEPTEMBER 12, 2022

Dr Prasanth Reddy, head of oncology at LabCorp, tells us how the company works with cancer care teams, biopharma partners, and patients as an integral part of the patient journey from testing to treatment. The oncology sector has transformed over the past several decades thanks to the rise of technological advances. Through partnerships and internal innovation, LabCorp is utilising these advances in order to improve healthcare stakeholders’ experiences for better patient results.

Patients 105

Patients Medicine FDA Healthcare 105

PharmaTimes

SEPTEMBER 12, 2022

Tislelizumab shows favourable safety profile compared to sorafenib among liver cancer patients

Safety 104

Safety Patients 104

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

MedCity News

SEPTEMBER 16, 2022

Yuvo Health launched a new initiative to provide FQHCs with administrative and managed contract services to help them adopt value-based care. The New York startup partnered with the Primary Care Development Corporation to co-develop training programs and support resources to ensure FQHCs are positioned for success in these care models.

Training 105

Training Management 105

Pharmatutor

SEPTEMBER 15, 2022

AN APPROACH TO THE HAIR FALL & HAIR GROWTH MANAGEMENT. About Authors Avdesh Thassu. MPharm (Nat. Chem.); MBA(Mkt.). Associate Vice President. Global Regulatory Affairs, Emami Limited, 7044455199. athassu@hotmail.com. Chandra Mohan Nandi. MSc. (Organic Chem.). Deputy Manager, Global Regulatory Affairs, Emami Limited, 9051706947 chandramohannandi@yahoo.in. admin.

Management 101

Management 101

pharmaphorum

SEPTEMBER 12, 2022

BioNTech has been thrust into the limelight with its mRNA-based vaccines and therapeutics – most notably its Pfizer-partnered COVID-19 shot – but the other side of its business is CAR-T therapies for cancer, and it is making progress in this area as well. At the ESMO congress the German biotech reported updated results from a phase 1/2 trial of its lead candidate BNT-211 for solid tumours, which consists of a CAR-T directed at the antigen Claudin-6 on cancer cells, coupled with an mRNA vaccine (

Patients 105

Patients Medicine Leads Medical 105

PharmaVoice

SEPTEMBER 16, 2022

The serial entrepreneur has relied on his gift for storytelling, creativity and a bit of “magic” as he’s launched one successful niche tech company after another.

98

98

Advertiser: ZoomInfo

Marketing technology is essential for B2B marketers to stay competitive in a rapidly changing digital landscape — and with 53% of marketers experiencing legacy technology issues and limitations, they’re researching innovations to expand and refine their technology stacks. To help practitioners keep up with the rapidly evolving martech landscape, this special report will discuss: How practitioners are integrating technologies and systems to encourage information-sharing between departments and pr

Competition

MedCity News

SEPTEMBER 16, 2022

For a long time, doctors’ offices, large or small, operated under a seeming contradiction; even […].

Doctors 105

Doctors Healthcare Healthcare Patients 105

Spotio

SEPTEMBER 16, 2022

Sales 98

Sales 98

pharmaphorum

SEPTEMBER 11, 2022

A personalised cell therapy based on tumour-infiltrating lymphocyte (TIL) cells has been shown to be more effective at improving progression-free survival than Bristol-Myers Squibb’s immunotherapy Yervoy in patients with advanced melanoma. It is the first time that a cell therapy for solid tumours has been tested in a phase 3 trial, and the first time that the approach has been directly compared with standard second-line immunotherapy in melanoma.

Side effects 105

Side effects Patients Engineering Management 105

PharmaVoice

SEPTEMBER 16, 2022

A combination of logic and love — that’s how the CEO of Waters Corp. leads and how he inspires those around him to “solve the problems that matter.

Leads 98

Leads 98

Advertisement

Distribution